Pain Patients Speak In Favor of Direct-to-Consumer Promotion by Pharma of Off-Label Use of Drugs In this 3-minute audio snippet, several anonymous pain patients and advocates tell why they are in favor of allowing pharmaceutical companies to promote or advertise off-label uses of drugs directly to patients.
These patients were interviewed via the inVibe platform, which engages research participants on their smartphones and collects responses via automated, voice-response surveys. Learn more at www.invibe.co.
The survey was done in preparation for FDA’s Part 15 public hearing on “Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products” on 9-10 November, 2016 (see below). Pharma Marketing News is also hosting a survey of readers on this topic (click survey box above or click here).
Your browser does not support the audio element. Upgrade your browser to one that does
In a Surprise Move, FDA Will Hold a Public Meeting to Review Off-label Marketing